Good direct announcement, backing up/solidifying the strong position ANP are in.
Especially like Mark's comment "it is our goal to bring this medication to as many DMD patients worldwide as possible". Now that's conviction.
Ann: US FDA Type C Meeting for ATL1102 in DMD, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.001(5.88%) |
Mkt cap ! $9.786M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $1.79K | 210K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 10989304 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1487417 | 6 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |